Table 3.
Variable | Non-coplanar intensity-modulated radiotherapy plan | Stereotactic body radiotherapy plan | p-value |
---|---|---|---|
Lung | |||
Mean lung dose (Gy) | 5.6 ± 2.1a | 6.9 ± 2.4 | <0.001 |
V5 (%) | 24.3 ± 9.0a | 28.8 ± 9.6 | <0.001 |
V10 (%) | 16.2 ± 6.4a | 18.7 ± 6.6 | <0.001 |
V15 (%) | 11.6 ± 4.8a | 13.5 ± 5.1 | 0.001 |
V20 (%) | 8.8 ± 3.8a | 10.8 ± 4.6 | <0.001 |
Spinal cord Dmax (Gy) | 10.8 ± 7.4a | 15.3 ± 8.6 | 0.002 |
Oesophageal Dmax (Gy) | 18.1 ± 17.2a | 22.3 ± 17.4 | <0.001 |
Heart Dmax (Gy) | 35.1 ± 29.1a | 39.9 ± 30.1 | <0.001 |
Heart Dmean (Gy) | 3.6 ± 4.6a | 5.2 ± 5.7 | 0.007 |
Dmax, maximal dose; Dmean, mean dose; V5, V10, V15, V20, lung receiving a dose >5, 10, 15 and 20 Gy.
Parameters are calculated by Wilcoxon single-rank test.
Significant difference.